scispace - formally typeset
Search or ask a question
Institution

Saint Louis University

EducationSt Louis, Missouri, United States
About: Saint Louis University is a education organization based out in St Louis, Missouri, United States. It is known for research contribution in the topics: Population & Health care. The organization has 18927 authors who have published 34895 publications receiving 1267475 citations. The organization is also known as: SLU & St. Louis University.


Papers
More filters
Journal ArticleDOI
TL;DR: In this paper, a 100+item chronology of entrepreneurship education in the USA from 1876 through 1999 is offered and analyzed, with the major findings being that the field has reached maturity and growth is likely outside business schools and outside the USA.

1,131 citations

Journal ArticleDOI
TL;DR: In this article, the authors present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes.
Abstract: In 2008, we published the first set of guidelines for standardizing research in autophagy. Since then, this topic has received increasing attention, and many scientists have entered the field. Our knowledge base and relevant new technologies have also been expanding. Thus, it is important to formulate on a regular basis updated guidelines for monitoring autophagy in different organisms. Despite numerous reviews, there continues to be confusion regarding acceptable methods to evaluate autophagy, especially in multicellular eukaryotes. Here, we present a set of guidelines for investigators to select and interpret methods to examine autophagy and related processes, and for reviewers to provide realistic and reasonable critiques of reports that are focused on these processes. These guidelines are not meant to be a dogmatic set of rules, because the appropriateness of any assay largely depends on the question being asked and the system being used. Moreover, no individual assay is perfect for every situation, calling for the use of multiple techniques to properly monitor autophagy in each experimental setting. Finally, several core components of the autophagy machinery have been implicated in distinct autophagic processes (canonical and noncanonical autophagy), implying that genetic approaches to block autophagy should rely on targeting two or more autophagy-related genes that ideally participate in distinct steps of the pathway. Along similar lines, because multiple proteins involved in autophagy also regulate other cellular pathways including apoptosis, not all of them can be used as a specific marker for bona fide autophagic responses. Here, we critically discuss current methods of assessing autophagy and the information they can, or cannot, provide. Our ultimate goal is to encourage intellectual and technical innovation in the field.

1,129 citations

Journal ArticleDOI
TL;DR: Nonalcoholic steatohepatitis can be a severe, progressive liver disease leading to the development of cirrhosis and should no longer be considered a disease predominantly seen in obese women with diabetes.

1,129 citations

Journal ArticleDOI
TL;DR: The treatment of psoriasis with etanercept led to a significant reduction in the severity of disease over a period of 24 weeks, paralleled by improvements in global assessments by physicians and the patients and in quality-of-life measures.
Abstract: Background Inflammatory cytokines such as tumor necrosis factor (TNF) have been implicated in the pathogenesis of psoriasis. We evaluated the safety and efficacy of etanercept, a TNF antagonist, for the treatment of plaque psoriasis. Methods In this 24-week, double-blind study, 672 patients underwent randomization and 652 either received placebo or received etanercept subcutaneously at a low dose (25 mg once weekly), a medium dose (25 mg twice weekly), or a high dose (50 mg twice weekly). After 12 weeks, patients in the placebo group began twice-weekly treatment with 25 mg of etanercept. The primary measure of clinical response was the psoriasis area-and-severity index. Results At week 12, there was an improvement from base line of 75 percent or more in the psoriasis area-and-severity index in 4 percent of the patients in the placebo group, as compared with 14 percent of those in the low-dose–etanercept group, 34 percent in the medium-dose–etanercept group, and 49 percent in the high-dose–etanercept group...

1,121 citations

Journal ArticleDOI
Jörg Kämper1, Regine Kahmann1, Michael Bölker2, Li-Jun Ma3, Thomas Brefort1, Barry J. Saville4, Barry J. Saville5, Flora Banuett6, James W. Kronstad7, Scott E. Gold8, Olaf Müller1, Michael H. Perlin9, Han A. B. Wösten10, Ronald P. de Vries10, Jose Ruiz-Herrera, Cristina G. Reynaga-Peña, Karen M. Snetselaar11, Michael P. McCann11, José Pérez-Martín12, Michael Feldbrügge1, Christoph W. Basse1, Gero Steinberg1, José I. Ibeas12, William K. Holloman13, Plinio Guzmán14, Mark L. Farman15, Jason E. Stajich16, Rafael Sentandreu17, Juan Manuel González-Prieto, John C. Kennell18, Lazaro Molina1, Jan Schirawski1, Artemio Mendoza-Mendoza1, Doris Greilinger1, Karin Münch1, Nicole Rössel1, Mario Scherer1, Miroslav Vranes1, Oliver Ladendorf1, Volker Vincon1, Uta Fuchs1, Björn Sandrock2, Shaowu Meng4, Eric C.H. Ho4, Matt J. Cahill4, Kylie J. Boyce7, Jana Klose7, Steven J. Klosterman8, Heine J. Deelstra10, Lucila Ortiz-Castellanos, Weixi Li15, Patricia Sánchez-Alonso14, Peter Schreier19, Isolde Häuser-Hahn19, Martin Vaupel19, Edda Koopmann19, Gabi Friedrich19, Hartmut Voss, Thomas Schlüter, Jonathan Margolis20, Darren Mark Platt20, Candace Swimmer20, Andreas Gnirke20, Feng Chen20, Valentina Vysotskaia20, Gertrud Mannhaupt1, Ulrich Güldener, Martin Münsterkötter, Dirk Haase, Matthias Oesterheld, Hans-Werner Mewes21, Evan Mauceli3, David DeCaprio3, Claire M. Wade3, Jonathan Butler3, Sarah Young3, David B. Jaffe3, Sarah E. Calvo3, Chad Nusbaum3, James E. Galagan3, Bruce W. Birren3 
02 Nov 2006-Nature
TL;DR: The discovery of the secreted protein gene clusters and the functional demonstration of their decisive role in the infection process illuminate previously unknown mechanisms of pathogenicity operating in biotrophic fungi.
Abstract: Ustilago maydis is a ubiquitous pathogen of maize and a well-established model organism for the study of plant-microbe interactions. This basidiomycete fungus does not use aggressive virulence strategies to kill its host. U. maydis belongs to the group of biotrophic parasites (the smuts) that depend on living tissue for proliferation and development. Here we report the genome sequence for a member of this economically important group of biotrophic fungi. The 20.5-million-base U. maydis genome assembly contains 6,902 predicted protein-encoding genes and lacks pathogenicity signatures found in the genomes of aggressive pathogenic fungi, for example a battery of cell-wall-degrading enzymes. However, we detected unexpected genomic features responsible for the pathogenicity of this organism. Specifically, we found 12 clusters of genes encoding small secreted proteins with unknown function. A significant fraction of these genes exists in small gene families. Expression analysis showed that most of the genes contained in these clusters are regulated together and induced in infected tissue. Deletion of individual clusters altered the virulence of U. maydis in five cases, ranging from a complete lack of symptoms to hypervirulence. Despite years of research into the mechanism of pathogenicity in U. maydis, no 'true' virulence factors had been previously identified. Thus, the discovery of the secreted protein gene clusters and the functional demonstration of their decisive role in the infection process illuminate previously unknown mechanisms of pathogenicity operating in biotrophic fungi. Genomic analysis is, similarly, likely to open up new avenues for the discovery of virulence determinants in other pathogens.

1,120 citations


Authors

Showing all 19076 results

NameH-indexPapersCitations
Douglas G. Altman2531001680344
John E. Morley154137797021
Roberto Romero1511516108321
Daniel S. Berman141136386136
Gregory J. Gores14168666269
Thomas J. Smith1401775113919
Richard T. Lee13181062164
George K. Aghajanian12127748203
Reza Malekzadeh118900139272
Robert N. Weinreb117112459101
Leslee J. Shaw11680861598
Thomas J. Ryan11667567462
Josep M. Llovet11639983871
Robert V. Farese11547348754
Michael Horowitz11298246952
Network Information
Related Institutions (5)
University of Pittsburgh
201K papers, 9.6M citations

95% related

University of North Carolina at Chapel Hill
185.3K papers, 9.9M citations

95% related

Yale University
220.6K papers, 12.8M citations

94% related

Duke University
200.3K papers, 10.7M citations

94% related

University of California, San Francisco
186.2K papers, 12M citations

94% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202344
2022233
20211,619
20201,600
20191,457
20181,375